Published in Blood Weekly, October 31st, 2002
Istvan Redei and colleagues at Emory University in Atlanta, Georgia evaluated the safety and efficacy of the FITFA conditioning regimen for patients treated with stem cells from partially mismatched related donors (PMRD).
Under the right circumstances, this regimen enables effective treatment using normal doses of PMRD stem cells, Redei and coauthors reported.
The researchers assessed outcomes in 19 adult patients who underwent the FITFA...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.